The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib hydrochloride combined with tislelizumab, paclitaxel liposome, and nedaplatin regimen for preoperative neoadjuvant therapy of esophageal cancer: A single-arm, single-center, phase II exploratory clinical study.
 
Jie Ma
No Relationships to Disclose
 
Cuizhen Liu
No Relationships to Disclose
 
Shi-xue Laoguo
No Relationships to Disclose
 
Huafu Zhou
No Relationships to Disclose
 
Yongyong Wang
No Relationships to Disclose
 
Jianji Guo
No Relationships to Disclose
 
Lihua Yang
No Relationships to Disclose
 
Jing Tang
No Relationships to Disclose
 
Rong Li
No Relationships to Disclose
 
Zhiming Zeng
No Relationships to Disclose
 
Lei Dai
No Relationships to Disclose
 
Ning Mo
No Relationships to Disclose
 
Jie Zeng
No Relationships to Disclose